Olinvacimab (Anti-VEGFR2 / KDR / CD309)

Olinvacimab (Anti-VEGFR2 / KDR / CD309) is a fully human monoclonal antibody targeting VEGFR2. It has antiangiogenic activity and can be used for the research of recurrent glioblastoma and breast cancer. MW :146.88 KD

• Supplier: Selleck Chemicals
• Product #: A2979
• Sku #: A2979-1mg*25